Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.30
-0.06 (-1.12%)
At close: Jun 26, 2026, 4:00 PM EDT
5.22
-0.08 (-1.51%)
After-hours: Jun 26, 2026, 6:34 PM EDT
Strata Critical Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Strata Critical Medical stock have an average target of 9.17, with a low estimate of 8.00 and a high estimate of 11.5. The average target predicts an increase of 73.02% from the current stock price of 5.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 7, 2026.
Analyst Ratings
The average analyst rating for Strata Critical Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 26, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +116.98% | May 7, 2026 |
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +50.94% | May 6, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $8 | Buy | Initiates | $8 | +50.94% | Mar 25, 2026 |
Financial Forecast
Revenue This Year
274.25M
from 197.14M
Increased by 39.11%
Revenue Next Year
303.63M
from 274.25M
Increased by 10.71%
EPS This Year
-0.14
EPS Next Year
-0.03
from -0.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 280.0M | 315.0M | |
| Avg | 274.3M | 303.6M | |
| Low | 268.1M | 289.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 42.0% | 14.9% | |
| Avg | 39.1% | 10.7% | |
| Low | 36.0% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.14 | -0.03 | |
| Avg | -0.14 | -0.03 | |
| Low | -0.14 | -0.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.